Amylin Pharmaceuticals (AMLN): Q2 EPS of -$0.36 misses by $0.01. Revenue of $209M (-6%) vs....

|By:, SA News Editor
Amylin Pharmaceuticals (AMLN): Q2 EPS of -$0.36 misses by $0.01. Revenue of $209M (-6%) vs. $205M. Shares +0.2% AH. (PR)